inflAmmatory maRkers in Blood and Thrombus Aspirated From Patients With acutE myocaRdial Infarction With St-segment elevAtion

NCT01757886 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-12-31

No results posted yet for this study

Summary

The prognostic value of inflammatory markers in acute coronary syndrome has been extensively demonstrated, however it is still unknown whether there is an association between circulating and local (thrombus) inflammatory molecules, and the subset of molecules that provide better prognostic information in patients with ST-elevation acute coronary syndrome.

Conditions

  • Patients Admitted With the Diagnosis of ST-elevation Acute Coronary Syndrome

Interventions

OTHER

Biomarkers to analyze both intracoronary thrombi as blood

Sponsors & Collaborators

  • Fundación Canaria Rafael Clavijo para la Investigación Biomédica

    lead OTHER

Principal Investigators

  • Alberto Dominguez-Rodriguez, MD, PhD · Hospital Universitario de Canarias

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2012-11-30
Completion
2013-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01757886 on ClinicalTrials.gov